dc.contributor.author |
Kienhorst, LB |
en |
dc.contributor.author |
van Lochem, E |
en |
dc.contributor.author |
Kievit, W |
en |
dc.contributor.author |
Dalbeth, Nicola |
en |
dc.contributor.author |
Merriman, ME |
en |
dc.contributor.author |
Phipps-Green, A |
en |
dc.contributor.author |
Loof, A |
en |
dc.contributor.author |
van Heerde, W |
en |
dc.contributor.author |
Vermeulen, S |
en |
dc.contributor.author |
Stamp, LK |
en |
dc.contributor.author |
van Koolwijk, E |
en |
dc.contributor.author |
de Graaf, J |
en |
dc.contributor.author |
Holzinger, D |
en |
dc.contributor.author |
Roth, J |
en |
dc.contributor.author |
Janssens, HJ |
en |
dc.contributor.author |
Merriman, TR |
en |
dc.contributor.author |
Broen, JC |
en |
dc.contributor.author |
Janssen, M |
en |
dc.contributor.author |
Radstake, TR |
en |
dc.date.accessioned |
2015-12-16T02:16:01Z |
en |
dc.date.issued |
2015-12 |
en |
dc.identifier.citation |
Arthritis and Rheumatology, 2015, 67 (12), pp. 3303 - 3313 |
en |
dc.identifier.issn |
2326-5191 |
en |
dc.identifier.uri |
http://hdl.handle.net/2292/27792 |
en |
dc.description.abstract |
OBJECTIVES: The frequent association with the metabolic syndrome and cardiovascular disease (CVD) suggest a systemic component in gout. Our objective was to study whether circulating pro-inflammatory cytokines are associated with comorbidities in gout patients. METHODS: We studied 330 gout patients from three independent cohorts and compared those with 144 healthy individuals and 276 disease controls. Circulating levels of IL-8 (CXCL8), IL-1b, IL-6, IL-10, IL-12, TNF-a were measured, after which proteome-wide analysis was performed in a selection of samples to determine possible prognostic proteins for the development of comorbidities. Replication analysis was performed specifically for MRP8/14. RESULTS: Compared to healthy and disease controls, patients with gouty arthritis (n=48) had significantly higher mean levels of CXCL8 (P < 0.001) whereas other cytokines were almost undetectable. Similarly, patients with intercritical gout also showed high levels of CXCL8. CXCL8 was independently associated (P<0.0001) with diabetes in intercritical gout patients. Proteome-wide analysis in gouty arthritis (n=18) and intercritical gout (n=39) revealed MRP8/14 as the protein with the greatest differential expression and correlation with CXCL8 (R(2) 0.49, P<0.001), which was replicated in an independent cohort. The proteome of gout patients with high CXCL8 was associated with diabetes (OR, 95% CI; 16.5, 2.8-96.6) and CVD (OR, 95% CI; 3.9, 1.0-15.3). CONCLUSIONS: Circulating levels of CXCL8 levels are increased during both the arthritis and intercritical phases of gout, and coincides with a specific circulating proteome that is associated with diabetes and CVD risk. Further research focussed on the role CXCL8 and MRP8/14 in patients with gout is warranted. This article is protected by copyright. |
en |
dc.format.medium |
Print-Electronic |
en |
dc.language |
eng |
en |
dc.publisher |
Wiley: 12 months |
en |
dc.relation.ispartofseries |
Arthritis and Rheumatology |
en |
dc.rights |
Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. Details obtained from http://olabout.wiley.com/WileyCDA/Section/id-820227.html
http://www.sherpa.ac.uk/romeo/issn/2326-5191/ |
en |
dc.rights.uri |
https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm |
en |
dc.title |
Gout is a chronic inflammatory disease where high levels of interleukin 8 (CXCL8), MRP8/14 and an altered proteome associate with diabetes and cardiovascular disease |
en |
dc.type |
Journal Article |
en |
dc.identifier.doi |
10.1002/art.39318 |
en |
pubs.issue |
12 |
en |
pubs.begin-page |
3303 |
en |
pubs.volume |
67 |
en |
dc.description.version |
AM - Accepted Manuscript |
en |
dc.rights.holder |
Copyright:
Wiley: 12 months |
en |
dc.identifier.pmid |
26248007 |
en |
pubs.end-page |
3313 |
en |
dc.rights.accessrights |
http://purl.org/eprint/accessRights/OpenAccess |
en |
pubs.subtype |
Article |
en |
pubs.elements-id |
495080 |
en |
pubs.org-id |
Medical and Health Sciences |
en |
pubs.org-id |
School of Medicine |
en |
pubs.org-id |
Medicine Department |
en |
dc.identifier.eissn |
2326-5205 |
en |
pubs.record-created-at-source-date |
2015-09-18 |
en |
pubs.dimensions-id |
26248007 |
en |